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{1} Thank you. I certainly don’t want to interfere in the American debate about labeling, since I have
already enough problems with European consumers, but what I would like to do today is not only to
talk about our legislation a bit, because it’s so detailed and complex, but also to talk about the European/
American trade relations, in particular as it relates to biotechnology. First of all, I would like to say
there is a strong trans-Atlantic relationship as far as trade is concerned between the EU and the U.S. We
have to realize that we have a trade level of around one billion dollars a day between us, without even
talking about investments. If you add investments, we’ll go up to one trillion dollars a year. Disputes,
because we have sometimes disputes and as it happens sometimes also in the families, represent only
two or three percent of the total business we have together.
{2} Today I would like to send a clear message about trade and biotechnology. I think it would be
a really big mistake for the U.S. to go forward with challenging the EU at the WTO on the so-called
moratorium. I don’t know if you are familiar with European Institutions, very quickly - you have the
European Commission, which is sort of the executive administration, and then you the Counsel of
Ministers which I would compare with the U.S. Senate, and then you have the European Parliament
which is similar to the U.S. House of Representatives. The European Commission and a series of
member states have come out now very clearly in favor of biotechnology.
{3} In spite of the suspicions of the European consumer, in general, the reasons why the European
Commission has come out with some member states in favor of biotechnology is ﬁrst of all, that all our
scientiﬁc studies and all the studies made by our scientiﬁc committees, have shown that GMO’s are safe
and in some cases safer than the traditional food. I have to be clear about that.
{4} The other concern is that the European biotech industry is really lagging behind. There is a real
brain drain from European companies going to the United States. The latest one is a Danish company
called Danisko which transferred its research center from Denmark to the United States. Considering
the uncertain situation, there is also a lack of investment in Europe. In other words, the whole industry
is in danger.
{5} The European Commission has published a communication on life sciences and biotechnology,
which was approved by the Council of Ministers (the Competitiveness Council) and also by the
European Parliament. Both of these bodies said that Europe should stop raising the suspicion on biotech
food products. The reason is that many jobs are being lost currently and thousands and thousands of
future jobs will not materialize. According to this communication, the future of the biotech industry by
2010 might well be a business of two trillion dollars world wide. I’m not, of course, talking only about
the food biotech industry - I’m also talking about pharmaceutical biotech, industrial biotech, and even
environmental biotech.
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{6} Furthermore, we have the European consumer. I won’t talk at length about the European consumer,
since I think that most of you now know that there is a large problem with the European consumer
and his distrust of GMO’s that originated with a series of food crisis which wrecked Europe and led to
waning consumer conﬁdence. The result is that the trust in GMO’s and at the same time the trust in the
regulator is really not there.
{7} In the European Union, we have a polling system which is called the Euro Barometer, and I had
hoped to have the ﬁgures of the latest Euro Barometer today, but the results will not be published until
next week. If you look at the ﬁgures of December 2001, you can see that in a poll over the ﬁfteen
countries of the EU, more than 56% of the people say that GM food is dangerous and 70.9% say they
don’t want this type of food. If something did happen, they say it would be a general disaster, and
94.6% of the European citizens believe that it is their right to choose through labeling. Not many people
in the United States know that we are currently having a European Convention, which is preparing a
European Constitution. But for the moment, our fundamental legal basis is the Treaty: Article 152 of
the Treaty of Rome, which says that being informed is a fundamental right of the consumer.
{8} One can talk at length about the rationality of the European consumer towards GMO’s, of course;
sufﬁce to say that Monsanto brought GMO’s onto the market during the height of the Mad Cow crisis.
Actually, it is a model of how not to market a product.
{9} Consumer conﬁdence was further eroded by scare mongering by tabloid newspapers, especially in
Austria and Great Britain, and certain NGO’s (non-governmental organizations). Moreover, besides bad
timing, the industry employed poor marketing strategy for the ﬁrst wave of products with agronomic
traits that beneﬁted only the farmer and offered no real added value for the consumer. Actually, there is
a real added value, since there is less pesticide use; however, the problem is that the biotech companies
still produce a lot of chemicals and pesticides, which represent their major income. They have,
therefore, a problem in sending a clear message to the consumer.
{10} The mismanagement of the BSE crisis by certain national governments and the resulting consumer
panic created a need for an EU wide response, namely the creation at the European level of a sort of
European FDA, the European Food Safety Authority, which will be up and running next month. At the
same time we wanted to modernize our regulatory food safety framework. The Commission came out
with a white paper on food safety in 2000. Its guiding principle is that food safety policy must be based
on a comprehensive integrated and science based approach.
{11} For food safety issues in general and biotech speciﬁcally, there is a crucial need to regain consumer
conﬁdence. I recognize that until the year 2000, the EU had an outdated, patchwork, and cumbersome
food legislation, which was not really adapted to deal with food and especially feed crisis. Remember
that feed contamination was the root of the majority of recent food crisis.
{12} Let us talk now about GMOs. Since 1990, the EU has had an approval system according to
which GMOs have to be approved case by case by a scientiﬁc committee, and later on by the member
states according to a sort of weighted voting system. Am I clear when I say weighted voting system?
Does everybody understand? Okay, to simplify, big countries have more votes than small countries.
In October 1998 ﬁve member states blocked the approval process under pressure from their public
opinions because of fear of eating GM food. These member states declared they were willing to
resume the approval process at the condition that new legislation was brought forward on labeling
and traceability, and that’s why the Commission came up with a new draft regulation on biotech.
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You should know, by the way, that in the EU, the Commission has the monopoly of proposing new
legislation, not the European Parliament.
{13} A new horizontal directive, which sets out rules for authorizing the deliberate release of live
GMOs into the environment, has been in place since October 2002. What is important is that the
Commission introduced in this directive for the ﬁrst time the principles of labeling and traceability.
These principles were then translated into two draft regulations. These two draft regulations ﬂesh out
the principles on traceability and labeling, and once in place, we think that member states will lift their
opposition.
{14} In the latest agriculture council, not ﬁve countries, but ten member states out of the ﬁfteen said
they were willing to lift the moratorium, or the so called moratorium, once the legislation is in place.
Where are we? Well I think that the legislation could be in place as soon as July, but let’s say to be on
the safe side, in October 2003.
{15} A few words about traceability and labeling. Traceability is not something new in Europe,
because we have already installed a traceability system after the BSE crisis for all the beef. I should
also add that traceability has now popped up in the United States because you have it in the Bioterrorism
Act and you have it also in the Country of Origin Labeling Act. Like the precautionary principle,
traceability appears to be a loaded term in some U.S. circles, and some people in the United States
pretend that it is not even English, it must be French.
{16} Traceability is deﬁned in the General Food Law as the ability to trace the history, application
or location of the entire entity by means of recorded identiﬁcation. There has been a very big
misunderstanding here in the United States. The traceability system we are proposing is exactly the
same as the one which is in the Bioterrorism Act: we want the paper trail going from the farm to the
fork, but not necessarily to the consumer. The system is one step back, one step forward and not more.
Traceability is there to facilitate targeted individual withdrawals should an unforeseen risk to human
health or the environment be established, as it happened in the United States with Starlink. It also
would allow targeted monitoring during ten years of potential effects on the environment. We would
also use it as a control and veriﬁcation of labeling claims.
{17} Why do I say this? Because we actually have already had labeling of GMOs - live GMOs - since
1997, but now we want to go further. We also want to label the ingredients if they are of a GM origin,
and we want to label starch products or highly reﬁned oils even if there are no traces anymore of DNA
or protein.
{18} The purpose of labeling is not to inform the consumer about the safety or the lack of safety of the
food, because if it’s not safe it can’t be put on the market. It is just a right to know and just the right to
make a choice. By the way, labeling in Europe is certainly not a way to trigger a warning as often is the
case in the United States.
{19} In conclusion, is it worth going to the WTO? Well, the internal procedure of the authorization
has restarted, and I think that by as early as July or October, ﬁve new GMO’s will be approved. I forgot
to mention that we have already approved eighteen GMO’s before the so called moratorium came into
place. We had already eighteen, but for the moment thirteen more are blocked in the pipeline.
{20} As I said, I think really that the ﬁve new GMO’s will be approved in the short-term. The
Commission has received sixteen others. It is the ﬁrst time since October 1998 that the process has
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restarted. So, to sum up, I think it would be a mistake to go to the WTO because it could freeze the
GM situation. In addition, considering the attitude of the European consumers and - let’s be frank - the
current anti-American feelings in Europe, we could even have a boycott of all American products, GM
and non-GM. I already mentioned the survival of our biotech industry; I think that’s also important. It
would be a mistake for the United States to be perceived as the only country which produces biotech
products. Thank you.
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